- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Lisa Hicks Discusses Quality Improvement
In order to really see quality improvement, it needs to be easier for physicians to access data and meet quality metrics, according to Lisa Hicks, MD, MSc.
In order to really see quality improvement, it needs to be easier for physicians to access data and meet quality metrics, according to Lisa Hicks, MD, MSc, who presented findings on the usefulness of the American Society of Hematology (ASH) Practice Improvement Modules, which define quality metrics, at the ASH Annual Meeting in December 2014.
Not only does quality improvement have to be easier for physicians, but the data should be presented in a nonjudgmental, non-punitive way, she added.
“I think if we can do that, more and more we’ll really see the benefits of monitoring quality and monitoring the care that we’re providing,” Dr Hicks said.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
